John L. Cleveland

31.4k total citations · 9 hit papers
224 papers, 22.7k citations indexed

About

John L. Cleveland is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, John L. Cleveland has authored 224 papers receiving a total of 22.7k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Molecular Biology, 67 papers in Oncology and 54 papers in Immunology. Recurrent topics in John L. Cleveland's work include Cancer-related Molecular Pathways (38 papers), Polyamine Metabolism and Applications (29 papers) and Cell death mechanisms and regulation (28 papers). John L. Cleveland is often cited by papers focused on Cancer-related Molecular Pathways (38 papers), Polyamine Metabolism and Applications (29 papers) and Cell death mechanisms and regulation (28 papers). John L. Cleveland collaborates with scholars based in United States, Germany and Sweden. John L. Cleveland's co-authors include Graham Packham, Joanne R. Doherty, James N. Ihle, Martine F. Roussel, Christine M. Eischen, Charles J. Sherr, Jonas A. Nilsson, Frank C. Dorsey, Kirsteen H. Maclean and Chunying Yang and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

John L. Cleveland

221 papers receiving 22.4k citations

Hit Papers

Toll-like receptor signal... 1991 2026 2002 2014 2007 1998 2013 1991 2007 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John L. Cleveland United States 78 14.8k 6.8k 4.7k 3.3k 3.3k 224 22.7k
David J. McConkey United States 95 15.9k 1.1× 7.2k 1.1× 3.7k 0.8× 2.2k 0.7× 4.2k 1.3× 385 27.3k
David C.S. Huang Australia 82 20.4k 1.4× 6.2k 0.9× 6.7k 1.4× 2.9k 0.9× 2.5k 0.8× 236 28.2k
Keiko Nakayama Japan 71 15.7k 1.1× 6.9k 1.0× 3.7k 0.8× 1.7k 0.5× 2.5k 0.7× 286 23.3k
Paul Dent United States 81 15.6k 1.1× 7.0k 1.0× 2.1k 0.4× 3.0k 0.9× 2.4k 0.7× 388 23.1k
Dario C. Altieri United States 94 22.4k 1.5× 9.0k 1.3× 5.8k 1.2× 2.1k 0.6× 4.5k 1.3× 256 31.2k
James A. McCubrey United States 79 16.1k 1.1× 6.8k 1.0× 3.2k 0.7× 1.6k 0.5× 3.9k 1.2× 421 24.9k
Robert T. Abraham United States 88 20.2k 1.4× 7.5k 1.1× 5.9k 1.2× 1.9k 0.6× 4.4k 1.3× 215 29.0k
Eric W.‐F. Lam United Kingdom 87 15.3k 1.0× 5.4k 0.8× 3.5k 0.7× 1.5k 0.5× 4.0k 1.2× 298 23.1k
Éric Solary France 75 12.5k 0.8× 4.9k 0.7× 5.3k 1.1× 1.9k 0.6× 2.2k 0.7× 369 21.5k
Yoshihide Tsujimoto Japan 85 18.8k 1.3× 4.3k 0.6× 4.0k 0.8× 4.8k 1.4× 2.4k 0.7× 184 28.6k

Countries citing papers authored by John L. Cleveland

Since Specialization
Citations

This map shows the geographic impact of John L. Cleveland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Cleveland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Cleveland more than expected).

Fields of papers citing papers by John L. Cleveland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Cleveland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Cleveland. The network helps show where John L. Cleveland may publish in the future.

Co-authorship network of co-authors of John L. Cleveland

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Cleveland. A scholar is included among the top collaborators of John L. Cleveland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Cleveland. John L. Cleveland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drápela, Stanislav, Didem Ilter, Dorina Avram, et al.. (2024). Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity. Oncogene. 44(2). 105–114. 4 indexed citations
2.
Fernandez, Mario R., Chunying Yang, Lancia Darville, et al.. (2023). Modulating the polyamine/hypusine axis controls generation of CD8+ tissue-resident memory T cells. JCI Insight. 8(18). 15 indexed citations
3.
Patel, Neil D., et al.. (2023). Novel Use of the ŌNŌ Retrieval System for Intracardiac Thrombectomy in a High-Risk Pediatric Patient. Journal of the Society for Cardiovascular Angiography & Interventions. 2(4). 100976–100976. 1 indexed citations
4.
Koomen, John M., Eric A. Welsh, Sujeewa Ranatunga, et al.. (2022). TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate. Cancer Immunology Research. 10(10). 1263–1279. 1 indexed citations
5.
Fernandez, Mario R., Franz X. Schaub, Chunying Yang, et al.. (2022). Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy. Cancer Research. 82(7). 1234–1250. 9 indexed citations
6.
Berglund, Anders, Robert J. Rounbehler, Shivanshu Awasthi, et al.. (2019). Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk. Cancer Epidemiology Biomarkers & Prevention. 29(1). 246–253. 17 indexed citations
7.
Cook, Leah M., Jeremy S. Frieling, Jeremy McGuire, et al.. (2019). Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. Oncogene. 38(44). 6959–6969. 24 indexed citations
8.
Rounbehler, Robert J., Anders Berglund, Travis Gerke, et al.. (2018). Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 27(11). 1376–1383. 7 indexed citations
9.
Schaub, Franz X., Md. Shamim Reza, Colin A. Flaveny, et al.. (2015). Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis. Cancer Research. 75(23). 5023–5033. 92 indexed citations
10.
Valentin-Vega, Yasmine A., Kirsteen H. Maclean, Jacqueline Tait-Mulder, et al.. (2011). Mitochondrial dysfunction in ataxia-telangiectasia. Blood. 119(6). 1490–1500. 291 indexed citations
11.
Old, Jennifer B., Susanne Kratzat, Alexander Hoellein, et al.. (2010). Skp2 Directs Myc-Mediated Suppression of p27Kip1 yet Has Modest Effects on Myc-Driven Lymphomagenesis. Molecular Cancer Research. 8(3). 353–362. 26 indexed citations
12.
Rounbehler, Robert J., Weimin Li, Mark A. Hall, et al.. (2009). Targeting Ornithine Decarboxylase Impairs Development of MYCN -Amplified Neuroblastoma. Cancer Research. 69(2). 547–553. 79 indexed citations
13.
Carew, Jennifer S., Steffan T. Nawrocki, Jerold E. Rehg, et al.. (2008). The Novel Polyamine Analogue CGC-11093 Enhances the Antimyeloma Activity of Bortezomib. Cancer Research. 68(12). 4783–4790. 23 indexed citations
14.
Nawrocki, Steffan T., Jennifer S. Carew, Leslie Douglas, et al.. (2007). Histone Deacetylase Inhibitors Enhance Lexatumumab-Induced Apoptosis via a p21Cip1-Dependent Decrease in Survivin Levels. Cancer Research. 67(14). 6987–6994. 52 indexed citations
15.
Keller, Ulrich, Jennifer B. Old, Frank C. Dorsey, et al.. (2007). Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. The EMBO Journal. 26(10). 2562–2574. 81 indexed citations
16.
Linggi, Bryan, Carsten Müller‐Tidow, Louis van de Locht, et al.. (2002). The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia. Nature Medicine. 8(7). 743–750. 202 indexed citations
17.
Braun, Johann, Jack Sublett, Dorette Freyer, et al.. (2002). Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis. Journal of Clinical Investigation. 109(1). 19–27. 20 indexed citations
18.
Pendeville, Hélène, Nick Carpino, Jean‐Christophe Marine, et al.. (2001). The Ornithine Decarboxylase Gene Is Essential for Cell Survival during Early Murine Development. Molecular and Cellular Biology. 21(19). 6549–6558. 200 indexed citations
19.
Packham, Graham, Jill M. Lahti, Brian E. Fee, et al.. (1997). Fas activates NF-κB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-α. Cell Death and Differentiation. 4(2). 130–139. 22 indexed citations
20.
Jenkins, Edward, et al.. (1977). Prevalence of Bordetella bronchiseptica Infection in Swine of Southeastern Alabama. American Journal of Veterinary Research. 38(12). 2071–2074. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026